The Department of Health and Human Services, through its Office for Civil Rights (OCR), has issued a clear notice that pro-lifers will welcome: pharmacies nationwide are no longer required to supply the abortion drug.
Under the Biden administration, policies in favor of abortion dramatically increased. In the wake of the Supreme Court’s 2022 Dobbs decision — which returned abortion regulation to the states and the people — the former administration issued guidance pressuring nearly 60,000 retail pharmacies to stock and dispense mifepristone and misoprostol for patients with Medicare, Medicaid, or other federally funded coverage. This move drew significant criticism and legal challenges from the onset, as many argued it overrode conscience rights and state laws.